Literature DB >> 6116509

Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversible beta-adrenoceptor antagonist.

K J Broadley, C D Nicholson.   

Abstract

1. Dissociation constant (KA) of isoprenaline and orciprenaline were determined for the positive inotropic and chronotropic responses of guinea-pig isolated atria. Cumulative dose-response curves to the agonists were constructed before and after incubation with and washout of the irreversible beta-adrenoreceptor antagonist, Ro 03-7894 1-(5-chloracetylaminobenzfuran-2-yl)-2-isopropylaminoethanol). 2. After 20 min washout, the curves were displaced to the right with depression of the maxima. After 3 h washout, there was only depression of the maxima. 3. Dissociation constants were determined by plotting reciprocals of molar concentrations before Ro 03-7894 (1/A) against reciprocals of the equiactive concentrations after Ro 03-7894 (1/A'). KA = (slope - 1)/ intercept. 4. Isoprenaline had a greater affinity (KA) than orciprenaline on both rate and tension. The affinity for rate and tension was identical for both agonists, indicating that the beta-adrenoceptors were identical. 5. Isoprenaline and orciprenaline produced identical rate response maxima when compared in the same preparation but the orciprenaline tension maximum was only 92.0 +/- 0.3% that of isoprenaline. 6. These dose-response curves were replotted as response against -log RA/Rt (fraction of receptors occupied) for each agonist concentration, calculated from the equation RA/Rt = (A)/(KA + (A)). The antilogarithm of the distance along the -log RA/Rt axis gave the efficacy of orciprenaline relative to isoprenaline. It had a greater efficacy (2.24) for rate but a lower efficacy for tension responses (0.5).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116509      PMCID: PMC2071640          DOI: 10.1111/j.1476-5381.1981.tb09143.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

2.  A quantitative study of beta-adrenergic receptors in rabbit atria.

Authors:  M Bristow; R D Green
Journal:  Eur J Pharmacol       Date:  1970-09-01       Impact factor: 4.432

3.  A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  J Pharm Pharmacol       Date:  1970-01       Impact factor: 3.765

4.  Evaluation of the cardiac effects of several beta adrenergic blocking agents.

Authors:  J R Blinks
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

5.  Differential inotropic--chronotropic action of thyronamine.

Authors:  J R Boissier; J F Giudicelli; S Larno; C Advenier
Journal:  Eur J Pharmacol       Date:  1973-05       Impact factor: 4.432

6.  Graphical and weighted regression analyses for the determination of agonist dissociation constants.

Authors:  C D Thron
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

7.  The pharmacological differentiation of adrenergic receptors.

Authors:  R F Furchgott
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

8.  Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.

Authors:  D Horii; T Kawada; K Takeda; S Imai
Journal:  Arzneimittelforschung       Date:  1974-09

Review 9.  Classification and properties of peripheral adrenergic receptors.

Authors:  D H Jenkinson
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

10.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

View more
  5 in total

1.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

2.  Is Ro 03-7894 an irreversible antagonist at beta-adrenoceptor sites?

Authors:  E Krstew; G A McPherson; E Malta; P Molenaar; C Raper
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

3.  Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.

Authors:  E N Juberg; K P Minneman; P W Abel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

4.  Temperature-induced changes in dissociation constants (KA) of agonists at cardiac beta-adrenoceptors determined by use of the irreversible antagonist Ro 03-7894.

Authors:  K J Broadley; R G Williams
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

5.  Irreversible blockade of beta-adrenergic receptors with a bromoacetyl derivative of pindolol.

Authors:  V Homburger; H Gozlan; R Bouhelal; M Lucas; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.